The novel coronavirus disease (COVID-19) pandemic has created a shift in the conduct of healthcare, particularly in the use of digital technology in enabling virtual experiences for both physicians and patients, as suggested by experts in the recently concluded 2020 Virtual Forum of the Asia Pacific Medical Technology Association (APACMed 2020).
From a typical brick-and-mortar environment to the application of digital and data technologies to engage patients at a safe distance, the pandemic has facilitated a shift in the delivery of healthcare.
The coronavirus disease (COVID-19) pandemic appears to have quickened the acceptance of prescription digital therapeutics (PDT), or software that helps treat human disease, by clinicians and patients, particularly those suffering from mental health conditions, according to experts from one of the sessions at the 2020 Virtual Forum of the Asia Pacific Medical Technology Association (APACMed 2020).
Digital technology is key in improving access to healthcare. This was the key message in one of the breakout sessions during the recently concluded 2020 Virtual Forum of the Asia Pacific Medical Technology Association (APACMed 2020). Especially under lockdowns due to the coronavirus pandemic, digital health allows providers to continuously deliver services to their patients.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.